…receive £10 million ($12.2 million) funding. Flexible and agile regulation Marc Bailey, MHRA Chief Science and Innovation Officer, said: “Our world-first Covid-19 approvals showed how important it is to ensure…

New findings suggest that the SARS-CoV-2 virus damages an important immune-cell response. The quality of CD8+ T cell response to two doses of the Pfizer-BioNTech Covid-19 vaccine was considerably lower…

…breast cancer, long Covid, bacterial diseases, bone cancer, and autoimmune conditions. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. https://www.ddw-online.com/ddw-highlights-21-march-2023-22648-202303/…

…metastatic breast cancer, long Covid, bacterial diseases, bone cancer, and autoimmune conditions. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts….

…be drug target in long Covid Researchers have shown for the first time that malfunctioning behaviour of a type of immune cell is linked to specific symptoms of long Covid….

…monocyte signatures defining subgroups of long Covid patients reveal new pathways that could targeted for novel therapeutic opportunities in long Covid patients. The research team was from The University of…

…Advances. Dr Kon explains: “So far mRNA vaccines, such as the Covid-19 vaccines familiar to all of us, were assumed to be effective against viruses but not against bacteria. The…

…Pfizer’s innovative medicines and vaccines portfolio. She previously led Pfizer UK’s Vaccines business unit during the Covid-19 pandemic. Commenting on her appointment, Rienow said: “I’m delighted to be taking up…

GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of Covid-19, (PASC, post-Covid or…

…the collaboration, the partners hope to enable better evidence-based treatments for common conditions, such as heart and kidney disease, hypertension, diabetes, stroke and Covid-19, by radically altering the way clinical…

…Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation in response to the Covid-19 pandemic. Its purpose is to accelerate the discovery and development of antiviral drugs…

…on the latest industry updates. Our news highlights this week focus on research into vaccines, with good news for the treatment or prevention of various challenging conditions, including Covid-19, Strep…

…on the latest industry updates. Our news highlights this week focus on research into vaccines, with good news for the treatment or prevention of various challenging conditions, including Covid-19, Strep…

…of various challenging conditions, including Covid-19, Strep A and HIV. Particularly interesting is the announcement that a new class of Covid-19 booster has outperformed approved vaccines in a head-to-head trial….

Covid-19 booster candidate UB-612 has achieved its immunogenicity endpoints in a head-to-head trial against three vaccine platforms: mRNA (Pfizer-BioNTech’s BNT162b2), adenovirus vector (AstraZeneca’s ChAdOx1-S), and inactivated virus (Sinopharm’s BIBP). The…

Researchers have revealed that vaccination against Covid-19 is associated with fewer heart attacks, strokes, and other cardiovascular issues among people who were infected with SARS-CoV-2. The conclusions are based on…